Kymera Therapeutics KYMR Purchases Of Property And Equipment Through Finance And Lease Liabilities

Purchases Of Property And Equipment Through Finance And Lease Liabilities at other companies

Paymentus HoldingsPAY

$0—

Paymentus HoldingsPAY

$0—

Cardinal Infrastructure Group, Inc.CDNL

$547.95K-24.3%

Palladyne AI Corp.PDYN

$28.25K—

Palladyne AI Corp.PDYN

$28.25K—

Spectrum Brands HoldingsSPB

$500K-92.4%

FAQ

What is Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities?

Kymera Therapeutics (KYMR) reported purchases of property and equipment through finance and lease liabilities of $257K in Q4 2025.

How has Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities changed year-over-year?

Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities decreased by 62.5% year-over-year, from $685.5K to $257K.

What is the long-term trend for Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities?

Over 4 years (2021 to 2025), Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities has grown at a -14.4% compound annual growth rate (CAGR), from $1.92M to $1.03M.

What does purchases of property and equipment through finance and lease liabilities mean?

Tracks the acquisition of property and equipment financed through specific lease or credit arrangements rather than direct cash purchases. This highlights the company's use of alternative financing structures to build out operational capacity.